Dyslipidemias in patients with HIV-associated lipodystrophic syndrome in a University Hospital in Pará
DOI:
https://doi.org/10.33448/rsd-v11i13.35446Keywords:
HIV; Dyslipidemia; Antiretrovirals.Abstract
The lipodystrophic syndrome in HIV is characterized by alterations in the distribution of body fat and metabolic alterations characterized by an increase in serum lipids; peripheral insulin resistance. The questionnaires applied were: a questionnaire to characterize adults with HIV/AIDS. The majority of respondents were male (66%), aged between 29 and 73 years old, with regard to education, 44% had completed high school. They were predominantly of low socioeconomic status. As for marital status, only 14% were married. As for the lipid variables, the mean total cholesterol levels in males (190.51 mg/dl) were higher than in females (189.16 mg/dl), but with a difference of only 1.35 mg/dl. dl, which makes a difference of little impact to the search. As for the triglycerides rate, the male average was 199.18 mg/dl, a value above the reference value limit established by the dyslipidemia guidelines, as well as the average value for females. The research has implications for professional practice, with the perception of the importance of observing, improving and intervening so that the demands of service users are met, aiming to direct actions aimed at their resolution and strengthening the patient's bond with health, in addition to improving lipid rates, in order to reduce the risk of cardiovascular disease.
References
Abbate, M. C. (2006). Lipodistrofia: Pessoas que vivem com HIV/Aids. Secretaria Municipal da Saúde de São Paulo.
Atualização da diretriz brasileira de dislipidemias e prevenção de aterosclerose. (2017) Sociedade Brasileira de Cardiologia • 109(2), 2017.
Bomfim, I. G.O. et. al. (2022). Qualidade de vida relacionada a saúde em pessoas vivendo com HIV/AIDS. braz j infect dis. 26(S2):102441.
Brasil (2009). Manual de tratamento da lipoatrofia facial: recomendações para o preenchimento facial com polimetilmetacrilato em portadores de HIV/AIDS / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de DST, AIDS e Hepatites Virais. – Brasília: Ministério da Saúde.
Brasil. (2021) Boletim Epidemiológico - Aids e DST –Número especial. Ministério da Saúde. Disponível em: www.aids.gov.br.
Burgos, M. G. P. A, et al. (2010). Alterações Nutricionais e Metabólicas em Pacientes com Aids em Uso de Terapia Antirretroviral. DST - J bras Doenças Sex Transm.; 22(3):118-122.
Cardoso, L. P. et al., (2020). Fatores de vulnerabilidade que geram o aumento dos casos de AIDS em idosos no Brasil. Braz. J. Hea. Rev., 3(2), 1650-1655.
Ceccato, M. G et al. (2011). Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil. Braz J Med Biol Res; 44:1177-1183.
Domingos H. (2006). Efeitos metabólicos associados à terapia anti-retroviral potente em pacientes com AIDS. [dissertação]. Programa Multinstitucional de Pós-Graduação em Ciências da Saúde. Convênio Centro-Oeste UnB/UFG/UFMS.
Fiuza, M. L. T. Religiosidade, adesão e qualidade de vida em pessoas vivendo com AIDS em uso de antirretrovirais. Dissertação (mestrado). Universidade Federal do Ceará, Fortaleza, 2012.
Fontes, R. S. et al. (2016). Perfil Antropométrico de Pacientes com Lipodistrofia do Município de Aracaju - SE. Congresso Internacional De Atividade Física, Nutrição E Saúde, (1). Recuperado de https://eventos.set.edu.br/CIAFIS/article/view/2700
Holmes, W.C. et al. (1998) A New HIV/AIDS Targeted Quality of life (HAT-QOL) Instrument: development, reliability and validity. Medical Care. 36: 138-54.
Lang, M, et al. (2012). Dislipidemias e Risco Cardiovascular em Pacientes Hiv-Positivo Utilizando Terapia Antirretroviral na Região Oeste de Santa Catarina. DST - J bras Doenças Sex Transm;24(4):246-249.
Montessori, V., et al. (2004). Adverse e ffects o f antiretroviral therapy for HIV infection. CMAJ 2004;170(2):229-38.
Nery, M.W. (2007). Dislipidemias em portadores de HIV/Aids em uso de terapia anti-retroviral [dissertação]. Universidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública; 2007.
Pereira A.S.et. al. (2018). Metodologia da pesquisa científica. UFSM.
Santos, E.C.M., et al. (2007). Qualidade de vida de pessoas vivendo com HIV/Aids em São Paulo. Rev Saúde Pública. 41(Supl. 2): 64-71.
Seidl, E.M.F. et al. (2008). Bem-estar psicológico, enfrentamento e lipodistrofia em pessoas vivendo com HIV/AIDS. Psicologia em Estudo, 13(2), 239-247.
Schmitz, M. F. & Crystal, S. (2000). Social relations, coping, and psychological distress among persons with HIV/AIDS. Journal of Applied Social Psychology. 665-685.
Silva, I.. R. P. et al. (2014). Dislipidemia e estado nutricional em pacientes HIV positivo com síndrome lipodistrófica. Rev Epidemiol Control Infect. 2014;4(3):200-207
Sterratino, G. et. al. (2012). Self-reported adherence suports patient preference for the single tablet regimen (STR) in the current cART era. Patient Prefer adherence, 6, 427-433.
Szogyenyi, G.V. et. al. (2022). Monitorizacao da função ao renal em e pessoas vivendo com HIV/AIDS (PVHA) em uso de dolutegravir: serie de casos. Braz J infect dis. 26(S2):102441
Yamano, E.Y.S. (2007). Alterações endócrinas e metabólicas em pacientes HIV positivos com lipodistrofia [dissertação]. Universidade Federal do Pará. Núcleo de Medicina Tropical. Belém, 1-72.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Débora Suellen de Oliveira Guimarães Lima; João Gabriel Barbosa Lima; Diana Domingas Silva do Rosário; Rosana Maria Feio Libonati
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
